Tsung‐Ching Lai

4.4k total citations · 1 hit paper
57 papers, 3.5k citations indexed

About

Tsung‐Ching Lai is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tsung‐Ching Lai has authored 57 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 19 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Tsung‐Ching Lai's work include Gold and Silver Nanoparticles Synthesis and Applications (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Tsung‐Ching Lai is often cited by papers focused on Gold and Silver Nanoparticles Synthesis and Applications (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Tsung‐Ching Lai collaborates with scholars based in Taiwan, United States and Switzerland. Tsung‐Ching Lai's co-authors include Michael Hsiao, Hsien‐Da Huang, Ann‐Ping Tsou, Ming‐Ta Hsu, Yi‐Hua Jan, Chih‐Jen Yang, Chung‐Hsuan Chen, Ming-Shyan Huang, Ru‐Shi Liu and Din Ping Tsai and has published in prestigious journals such as Journal of Clinical Investigation, Hepatology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Tsung‐Ching Lai

56 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

2012 670 citations Wei-Chih Tsai, Sheng‐Da Hsu et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tsung‐Ching Lai Taiwan	26	2.1k	1.4k	471	385	383	57	3.5k
Ling Zhu China	28	1.6k 0.7×	605 0.4×	456 1.0×	263 0.7×	666 1.7×	130	2.8k
Xiaomei Yang China	37	2.0k 1.0×	969 0.7×	583 1.2×	384 1.0×	215 0.6×	111	3.6k
Jiandong Wang China	29	1.3k 0.6×	670 0.5×	553 1.2×	471 1.2×	519 1.4×	139	3.3k
Feiyue Fan China	27	1.5k 0.7×	466 0.3×	500 1.1×	564 1.5×	344 0.9×	60	2.9k
Hongyi Zhang China	31	1.7k 0.8×	775 0.6×	724 1.5×	466 1.2×	264 0.7×	154	4.2k
Diane Braguer France	39	2.3k 1.1×	536 0.4×	1.1k 2.4×	330 0.9×	484 1.3×	104	4.6k
Shamit K. Dutta United States	31	1.6k 0.8×	565 0.4×	723 1.5×	198 0.5×	350 0.9×	62	2.6k
Zhuan Zhou China	32	2.0k 0.9×	635 0.5×	698 1.5×	206 0.5×	279 0.7×	81	3.0k
Yue Jin China	32	1.5k 0.7×	737 0.5×	529 1.1×	109 0.3×	349 0.9×	90	2.7k
Hyewon Youn South Korea	30	1.6k 0.8×	493 0.4×	500 1.1×	298 0.8×	1.0k 2.6×	108	3.6k

Countries citing papers authored by Tsung‐Ching Lai

Since Specialization

Citations

This map shows the geographic impact of Tsung‐Ching Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung‐Ching Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung‐Ching Lai more than expected).

Fields of papers citing papers by Tsung‐Ching Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung‐Ching Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung‐Ching Lai. The network helps show where Tsung‐Ching Lai may publish in the future.

Co-authorship network of co-authors of Tsung‐Ching Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung‐Ching Lai. A scholar is included among the top collaborators of Tsung‐Ching Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung‐Ching Lai. Tsung‐Ching Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Tsung‐Ching, Ayushi Sharma, Jer‐Hwa Chang, et al.. (2025). A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models. Biomedicine & Pharmacotherapy. 191. 118470–118470.

Lai, Tsung‐Ching, Yu-Chieh Chen, Yi‐Chieh Yang, et al.. (2023). Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer. Cancers. 15(13). 3288–3288. 5 indexed citations

Li, Lijie, Chien‐Hsiu Li, Peter Mu‐Hsin Chang, et al.. (2022). Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling. Frontiers in Oncology. 12. 775541–775541. 8 indexed citations

Li, Lijie, Peter Mu‐Hsin Chang, Chien‐Hsiu Li, et al.. (2022). FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis. Cell Death Discovery. 8(1). 101–101. 18 indexed citations

Hu, Yu‐Feng, Tsung‐Ching Lai, Yu‐Chan Chang, et al.. (2021). ALDH2 deficiency induces atrial fibrillation through dysregulated cardiac sodium channel and mitochondrial bioenergetics: A multi-omics analysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(5). 166088–166088. 12 indexed citations

Yang, Yi‐Fang, Yen‐Yun Wang, Michael Hsiao, et al.. (2020). IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway. Cancer Letters. 485. 27–37. 16 indexed citations

Jan, Yi‐Hua, Tsung‐Ching Lai, Chih‐Jen Yang, Ming‐Shyan Huang, & Michael Hsiao. (2019). A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma. Scientific Reports. 9(1). 12329–12329. 23 indexed citations

Chien, Ming‐Hsien, Wei‐Min Chang, Wei-Jiunn Lee, et al.. (2017). A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio. Molecular Cancer Therapeutics. 16(6). 1102–1113. 18 indexed citations

Chang, Wei‐Min, Yuan‐Feng Lin, Chia‐Yi Su, et al.. (2016). Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Cancer Research. 76(24). 7140–7150. 41 indexed citations

10.

Lai, Tsung‐Ching, et al.. (2016). Selective killing of cancer cells by nanoparticle-assisted ultrasound. Journal of Nanobiotechnology. 14(1). 46–46. 45 indexed citations

11.

Yang, Yi‐Fang, Yi‐Hua Jan, Yu‐Peng Liu, et al.. (2014). Squalene Synthase Induces Tumor Necrosis Factor Receptor 1 Enrichment in Lipid Rafts to Promote Lung Cancer Metastasis. American Journal of Respiratory and Critical Care Medicine. 190(6). 675–687. 59 indexed citations

12.

Lin, Yuan‐Feng, Tsung‐Ching Lai, Chih‐Kang Chang, et al.. (2013). Targeting the XIAP/caspase-7 complex selectively kills caspase-3–deficient malignancies. Journal of Clinical Investigation. 123(9). 3861–3875. 25 indexed citations

13.

Cheng, Liang‐Chien, Hao Ming Chen, Tsung‐Ching Lai, et al.. (2013). Targeting polymeric fluorescent nanodiamond-gold/silver multi-functional nanoparticles as a light-transforming hyperthermia reagent for cancer cells. Nanoscale. 5(9). 3931–3931. 47 indexed citations

14.

Liu, Yu‐Peng, Chih‐Jen Yang, Ming-Shyan Huang, et al.. (2012). Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling. Cancer Research. 73(1). 406–416. 180 indexed citations

15.

Tsai, Wei-Chih, Sheng‐Da Hsu, Tsung‐Ching Lai, et al.. (2012). MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. Journal of Clinical Investigation. 122(8). 2884–2897. 670 indexed citations breakdown →

16.

Peng, Jei‐Ming, Yee‐Hsiung Chen, Shao‐Wen Hung, et al.. (2011). Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to down‐regulate Akt and MMP‐2. British Journal of Pharmacology. 165(2). 479–493. 20 indexed citations

17.

Chen, Min-Wei, Kuo‐Tai Hua, Lin‐Hung Wei, et al.. (2010). H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM. Cancer Research. 70(20). 7830–7840. 297 indexed citations

18.

Lo, Chi‐Wen, Min‐Wei Chen, Michael Hsiao, et al.. (2010). IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer. Cancer Research. 71(2). 424–434. 152 indexed citations

19.

Tsai, Wei-Chih, Paul Wei‐Che Hsu, Tsung‐Ching Lai, et al.. (2008). MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma #. Hepatology. 49(5). 1571–1582. 492 indexed citations

20.

Hsiao, Michael, et al.. (2008). Defective Phosphatidylinositol 3-Kinase Signaling in Central Control of Cardiovascular Effects in the Nucleus Tractus Solitarii of Spontaneously Hypertensive Rats. Hypertension Research. 31(6). 1209–1218. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact